rs121918649
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PM2PP3_ModeratePP5
The NM_001355436.2(SPTB):c.6074T>G(p.Leu2025Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: not found (cov: 33)
Consequence
SPTB
NM_001355436.2 missense
NM_001355436.2 missense
Scores
13
4
2
Clinical Significance
Conservation
PhyloP100: 9.28
Genes affected
SPTB (HGNC:11274): (spectrin beta, erythrocytic) This locus encodes a member of the spectrin gene family. Spectrin proteins, along with ankyrin, play a role in cell membrane organization and stability. The protein encoded by this locus functions in stability of erythrocyte membranes, and mutations in this gene have been associated with spherocytosis type 2, hereditary elliptocytosis, and neonatal hemolytic anemia. Alternatively spliced transcript variants have been described. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 5 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.87
PP5
Variant 14-64767808-A-C is Pathogenic according to our data. Variant chr14-64767808-A-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 12839.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=1, Likely_pathogenic=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPTB | NM_001355436.2 | c.6074T>G | p.Leu2025Arg | missense_variant | 30/36 | ENST00000644917.1 | NP_001342365.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPTB | ENST00000644917.1 | c.6074T>G | p.Leu2025Arg | missense_variant | 30/36 | NM_001355436.2 | ENSP00000495909.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:3Uncertain:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
ANEMIA, PERINATAL HEMOLYTIC, FATAL OR NEAR-FATAL Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 01, 1995 | - - |
SPTB-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 12, 2024 | The SPTB c.6074T>G variant is predicted to result in the amino acid substitution p.Leu2025Arg. This variant is also known as spectrin Buffalo and has been noted to be common in individuals with hemolytic anemia in the Thai population (Songdej et al. 2024. PubMed ID: 35819869). It has been reported in the homozygous or compound heterozygous states in individuals with severe inherited hemolytic anemia (Gallagher et al. 1997. PubMed ID: 9005995; Ittiwut et al. 2018. PubMed ID: 30198572; Songdej et al. 2024. PubMed ID: 37996759). Individuals heterozygous for this variant have been reported to have a milder elliptocytosis phenotype (Gallagher et al. 1997. PubMed ID: 9005995; Songdej et al. 2024. PubMed ID: 37996759). This variant has not been reported in a large population database, indicating this variant is rare. This variant is interpreted to be pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jan 26, 2023 | - - |
Hereditary spherocytosis type 2 Uncertain:1
Uncertain significance, criteria provided, single submitter | research | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Dec 03, 2018 | The heterozygous p.Leu2025Arg variant in SPTB was identified by our study in one individual with spherocytosis. This variant was absent from large population studies. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical significance of the p.Leu2025Arg variant is uncertain. ACMG/AMP Criteria applied: PM2, PP3 (Richards 2015). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;.;T;D;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
.;.;D;D;.;D
M_CAP
Uncertain
D
MetaRNN
Pathogenic
D;D;D;D;D;D
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
H;H;H;.;H;H
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;.;D;D;D;D
REVEL
Pathogenic
Sift
Pathogenic
D;.;D;D;D;D
Sift4G
Pathogenic
D;.;D;D;D;D
Polyphen
1.0
.;.;.;.;D;D
Vest4
MutPred
Gain of MoRF binding (P = 0.0682);Gain of MoRF binding (P = 0.0682);Gain of MoRF binding (P = 0.0682);.;Gain of MoRF binding (P = 0.0682);Gain of MoRF binding (P = 0.0682);
MVP
MPC
0.93
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at